Details for New Drug Application (NDA): 202394
✉ Email this page to a colleague
The generic ingredient in ENTACAPONE is entacapone. There are twenty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the entacapone profile page.
Summary for 202394
Tradename: | ENTACAPONE |
Applicant: | Mylan Pharms Inc |
Ingredient: | entacapone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | May 13, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription